| Pediatric Transition
of Care
Click
here for Senate letter to GAO.
The AST Public Policy Committee
is a leading voice on Capitol Hill, within the Executive Branch,
and in State Capitols on important issues impacting the field
of solid organ transplantation. Members of the Society’s
Public Policy Committee regularly travel to Washington, DC,
to educate and deliver the organization’s public policy
agenda directly to key federal decision-makers and their staff.
AST also maintains a full-time advocacy office in the nation’s
capitol.
In the past, AST leaders have
been called upon to provide testimony, as well as serve on
advisory panels to Congress, State legislatures, the National
Institutes of Health, Institutes of Medicine, Centers for
Medicaid and Medicare Services, the Office of the Secretary-Department
of Health and Human Services, Food and Drug Administration,
Centers for Disease Control, etc.
The AST has been instrumental in assisting
federal and state public policy decision-makers in the crafting
and formation of a variety of legislative and regulatory initiatives.
Information is provided to Congress and key officials in the
Executive Branch about the organization’s views and
positions as determined by the Public Policy Committee and
the Board of Directors. Through these efforts, the AST represents
the interests of physicians and scientists in all solid organ
transplantation specialties.
|
